Cargando…

Safety of intravenously applied mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer

BACKGROUND: Mistletoe extracts have anti-tumor properties and are approved for subcutaneous use in cancer patients. Data on Intravenous application are limited. METHODS: An aqueous extract from pine-mistletoe was used to investigate maximum tolerable dose (MTD) and safety of intravenous application....

Descripción completa

Detalles Bibliográficos
Autores principales:	Huber, Roman, Schlodder, Dietrich, Effertz, Carola, Rieger, Sabine, Tröger, Wilfried
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604151/ https://www.ncbi.nlm.nih.gov/pubmed/28923036 http://dx.doi.org/10.1186/s12906-017-1971-1

Ejemplares similares

Fever Therapy With Intravenously Applied Mistletoe Extracts for Cancer Patients: A Retrospective Study
por: Schläppi, Marc, et al.
Publicado: (2016)

Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study
por: Pelzer, Florian, et al.
Publicado: (2018)

Supportive mistletoe therapy in a patient with metastasised neuroblastoma
por: Kaestner, Jens, et al.
Publicado: (2019)

Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer
por: Paller, Channing J., et al.
Publicado: (2023)

Quality of Life and Neutropenia in Patients with Early Stage Breast Cancer: A Randomized Pilot Study Comparing Additional Treatment with Mistletoe Extract to Chemotherapy Alone
por: Tröger, Wilfried, et al.
Publicado: (2009)

Additional Therapy with a Mistletoe Product during Adjuvant Chemotherapy of Breast Cancer Patients Improves Quality of Life: An Open Randomized Clinical Pilot Trial
por: Tröger, Wilfried, et al.
Publicado: (2014)

Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study
por: Steele, Megan L., et al.
Publicado: (2014)

Difficulties and Perspectives of Immunomodulatory Therapy with Mistletoe Lectins and Standardized Mistletoe Extracts in Evidence-Based Medicine
por: Hajtó, Tibor, et al.
Publicado: (2011)

Evaluation of Preclinical Assays to Investigate an Anthroposophic Pharmaceutical Process Applied to Mistletoe (Viscum album L.) Extracts
por: Baumgartner, Stephan, et al.
Publicado: (2014)

Mistletoe as an Oxytoxic
Publicado: (1878)

The Mistletoe Bough
Publicado: (1871)

Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma – a randomized, controlled pilot study
por: Kim, Kab-Choong, et al.
Publicado: (2012)

Safety and effects of two mistletoe preparations on production of Interleukin-6 and other immune parameters - a placebo controlled clinical trial in healthy subjects
por: Huber, Roman, et al.
Publicado: (2011)

Mistletoe as an Anti-Hemorrhagic
Publicado: (1881)

Impact of Mistletoe Triterpene Acids on the Uptake of Mistletoe Lectin by Cultured Tumor Cells
por: Mulsow, Katharina, et al.
Publicado: (2016)

Milling the Mistletoe: Nanotechnological Conversion of African Mistletoe (Loranthus micranthus) Intoantimicrobial Materials
por: Sarfraz, Muhammad, et al.
Publicado: (2018)

Fermented Mistletoe Extract as a Multimodal Antitumoral Agent in Gliomas
por: Podlech, Oliver, et al.
Publicado: (2012)

The Potential Role of Korean Mistletoe Extract as an Anti-Inflammatory Supplementation
por: Ha, Soo-Min, et al.
Publicado: (2021)

Model-Informed Development of Sotalol Loading and Dose Escalation Employing an Intravenous Infusion
por: Somberg, John C., et al.
Publicado: (2020)

An Exploratory Dose-Escalating Study Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous Atacicept in Patients with Systemic Lupus Erythematosus
por: Pena-Rossi, C, et al.
Publicado: (2009)

Dose escalation study to evaluate safety, tolerability and efficacy of intravenous etoposide phosphate administration in 27 dogs with multicentric lymphoma
por: Boyé, Pierre, et al.
Publicado: (2017)

Safety and tolerability of escalating cannabinoid doses in healthy cats
por: Kulpa, Justyna E, et al.
Publicado: (2021)

Efficacy and safety of tofacitinib dose de‐escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open
por: Sands, Bruce E., et al.
Publicado: (2019)

Plastome Evolution in Hemiparasitic Mistletoes
por: Petersen, Gitte, et al.
Publicado: (2015)

American Mistletoe as an Oxytocic and Emmenagogue
por: Carter, J. M. G.
Publicado: (1888)

NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors
por: Mansky, Patrick J., et al.
Publicado: (2013)

P1535: SAFETY AND TOLERABILITY OF SINGLE ESCALATING DOSES OF INTRAVENOUS NIPOCALIMAB IN HEALTHY JAPANESE ADULTS: A RANDOMIZED, PHASE 1 PLACEBO-CONTROLLED STUDY
por: Leu, J., et al.
Publicado: (2022)

Preliminary Investigation of the Safety of Escalating Cannabinoid Doses in Healthy Dogs
por: Vaughn, Dana, et al.
Publicado: (2020)

Erratum to “NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors”
por: Mansky, Patrick J., et al.
Publicado: (2014)

A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Carcinomatosis
por: Robella, Manuela, et al.
Publicado: (2021)

Biology and classification of dwarf mistletoes (Arceuthobium)
por: Hawksworth, Frank G., 1926-
Publicado: (1972)

Emerging roles of mistletoes in malignancy management
por: Patel, Seema, et al.
Publicado: (2013)

A Hidden Treasure: The Borneo Mistletoes
por: Lim, Ya Chee, et al.
Publicado: (2017)

Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
por: Wheeler, Graham M.
Publicado: (2016)

Mistletoe Extracts from Different Host Trees Disparately Inhibit Bladder Cancer Cell Growth and Proliferation
por: Juengel, Eva, et al.
Publicado: (2023)

Safety, tolerability, pharmacokinetics and pharmacodynamics of parenterally administered dutogliptin: A prospective dose‐escalating trial
por: Buchtele, Nina, et al.
Publicado: (2020)

Phase I dose escalation safety study of nanoparticulate paclitaxel (CTI 52010) in normal dogs
por: Axiak, Sandra M, et al.
Publicado: (2011)

Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study
por: Sarantopoulos, John, et al.
Publicado: (2017)

Phase I dose-escalation, safety, and CNS pharmacokinetic study of dexanabinol in patients with brain cancer
por: Juarez, Tiffany M, et al.
Publicado: (2021)

Study Protocol: Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Metastases
por: Robella, Manuela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hjf52dibmui8bf1d0nmke99ok1